Whether simply associated with trisomy 21, such as mucoviscidosis (cystic fibrosis), or a genuine comorbidity, such as pulmonary hemosiderosis, although these two lung pathologies are rare – indeed very rare – they need to be thoroughly understood.

In the video and accompanying technical sheet, Dr. Hervé Walti, a pediatrician at the Jérôme Lejeune Institute, tells you more.  He talks about their often atypical forms of presentation – which can potentially delay diagnosis – their often more severe progression, and finally their management, which should have the same treatment opportunities as neurotypical patients.